NBS10 (Also Known as AMR-001) Versus Placebo Post ST Segment Elevation Myocardial Infarction

PHASE2CompletedINTERVENTIONAL
Enrollment

195

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

June 30, 2014

Study Completion Date

April 30, 2016

Conditions
ST Segment Elevation Myocardial Infarction
Interventions
BIOLOGICAL

NBS10

dosage = 10 or more million CD34+ cells via intracoronary infusion

OTHER

placebo

matching placebo

Trial Locations (58)

10532

Westchester Medical Center, Valhalla

11219

Maimonides Medical Center-Brooklyn, Brooklyn

14203

Buffalo General Medical Center/Roswell Park Cancer Institute, Buffalo

15213

University of PIttsburg Medical Center, Pittsburgh

17822

Geisinger Medical Center, Danville

19102

Drexel University/Hahnemann University Medical Center, Philadelphia

20010

MedStar Washington Hospital Center, Washington D.C.

21201

University of Maryland Med Center, Baltimore, Baltimore

22908

UVA Health System Cardiology Research, Charlottesville

25401

Centra Lynchburg General Hospital, Lynchburg

28024

Presbyterian CVI Research, Charlotte

28054

CaroMont Heart, Gastonia

30322

Emory University Medical Center, Atlanta

30342

St. Joseph's Research Institute, Atlanta

30501

Northeast Georgia Heart Center, Gainesville

32610

University of Florida-Gainesville, Gainesville

32806

Orlando Health Medical Center, Orlando

33513

Pepin Heart Institute - Florida Hospital -Tampa, Tampa

35294

University of Alabama Birmingham, Birmingham

35801

Heart Center Research, LLC (Huntsville Hospital), Huntsville

38138

Stern Cardiovascular Foundation/Baptist Hospital, Memphis

38801

Cardiology Asociates Research LLC, Tupelo

40207

Louisville Cardiology Medical Group, Louisville

40536

University of Kentucky, Gill Heart Institute, Lexington

43210

Ohio State University Medical Center, Columbus

45219

The Carl and Edyth Lindner Center for Research and Education at the Christ Hospital, Cincinnati

45267

University of Cincinnati, Cincinnati

46260

St. Vincent's Medical Group/St. Vincent's Heart Center of Indiana, Indianapolis

48109

University of Michigan, Ann Arbor

48201

Detroit Medical Center, Detroit

48202

Henry Ford Health Systems, Detroit

48334

Detroit Clinical Research Center PC, Farmington Hills

53233

Aurora Health Care Metro, Inc/St. Lukes Medical Center, Milwaukee

55407

Minneapolis Heart Institute, Minneapolis

55905

Mayo Clinic, Rochester

60126

Advocate Health and Hospital Corp., Elmhurst

60515

Advocate Health and Hospital Corp., Downer's Grove

60611

Northwestern University, Chicago

60612

Rush University Medical Center, Chicago

66160

Kansas University Medical Center, Kansas City

73104

University of Oklahoma Health and Sciences Center, Oaklahoma City

77030

Texas Heart Institute, Houston

University of Texas Health Science Center at Houston, Houston

77555

University of Texas Medical Branch - Galveston, Galveston

78229

Methodist Health Systems of San Antonio, San Antonio

78756

Austin Heart, Austin

84132

University of Utah Hospital, Salt Lake City

85054

Mayo Clinic - Arizona, Phoenix

85297

Mercy Gilbert Medical Group, Gilbert

90033

Keck School of Medicine - University of Southern California, Los Angeles

92037

Scripps-La Jolla, CA, La Jolla

93030

St.Johns Regional Hospital and Medical Center, Oxnard

94305

Standford University School of Medicine, Stanford

01702

Metrowest Medical Center, Framingham

07601

Hackensack University Medical Center, Hackensack

07103

University of Medicine and Dentistry of New Jersey, Newark

11794-8167

Stony Brook University Hospital and Medical Center, Stony Brook

02904

Miriam Hospital, Providence

Sponsors
All Listed Sponsors
lead

Lisata Therapeutics, Inc.

INDUSTRY

NCT01495364 - NBS10 (Also Known as AMR-001) Versus Placebo Post ST Segment Elevation Myocardial Infarction | Biotech Hunter | Biotech Hunter